INS and Hypoglycemia: Recent guidelines provide general recommendations for the use of crystalloids and intravenous insulin in DKA, and for rapid correction of hypoglycemia [6], but emerging studies suggest that tailored approaches - considering patient age, severity, comorbidities, and specific pharmacokinetic properties of interventions - may optimize outcomes [7].